Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Abrams

Showing results (101-110 of 371) with videos related to

Pageof 38
Sort By:
Molecular Immunology|December 30, 2019
Myeloid-driven mechanisms as barriers to antitumor CD8<sup>+</sup> T cell activitySean H Colligan, Stephanie L Tzetzo, Scott I Abrams
American Journal of Hematology|November 1, 1991
Continuous, low-dose therapy with interferon-alpha for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpuraD W Northfelt, L D Kaplan, D I Abrams
The Journal of School Health|June 1, 1971
Improving the quality of life. II Abrams, L G Daugherty, R S Abrams, et al.
Cancer Investigation|March 5, 2008
Immune consequences of protracted host-tumor interactions in a transgenic mouse model of mammary carcinomaTrina J Stewart, M E Christine Lutsiak, Scott I Abrams
Advances in Cancer Research|July 25, 2006
Cancer vaccines: preclinical studies and novel strategiesClaudia Palena, Scott I Abrams, Jeffrey Schlom, et al.
Journal of Leukocyte Biology|March 21, 2017
The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in diseaseDanielle Y F Twum, Lauren Burkard-Mandel, Scott I Abrams
Prehospital and Disaster Medicine|March 9, 1993
Guidelines for rescue training of the lay publicJ I Abrams, E A Pretto, D Angus, et al.
Current Infectious Disease Reports|May 22, 2014
Non-AIDS-Defining Malignancies in the HIV-Infected PopulationChia-Ching J Wang, Michael J Silverberg, Donald I Abrams
Cellular Immunology|March 1, 1993
Detachment and lysis of adherent target cells by CD4+ T cell clones involve multiple effector mechanismsS I Abrams, R Wang, W E Munger, et al.
MEDICC Review|May 19, 2018
Case Study in International Cooperation: Cuba's Molecular Immunology Center and Roswell Park Cancer InstituteRachel Evans, Mary Reid, Brahm Segal, et al.
Pageof 38

Showing results (101-110 of 371) with videos related to

Sort By:
Pageof 38
Molecular Immunology|December 30, 2019
Myeloid-driven mechanisms as barriers to antitumor CD8<sup>+</sup> T cell activitySean H Colligan, Stephanie L Tzetzo, Scott I Abrams
American Journal of Hematology|November 1, 1991
Continuous, low-dose therapy with interferon-alpha for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpuraD W Northfelt, L D Kaplan, D I Abrams
The Journal of School Health|June 1, 1971
Improving the quality of life. II Abrams, L G Daugherty, R S Abrams, et al.
Cancer Investigation|March 5, 2008
Immune consequences of protracted host-tumor interactions in a transgenic mouse model of mammary carcinomaTrina J Stewart, M E Christine Lutsiak, Scott I Abrams
Advances in Cancer Research|July 25, 2006
Cancer vaccines: preclinical studies and novel strategiesClaudia Palena, Scott I Abrams, Jeffrey Schlom, et al.
Journal of Leukocyte Biology|March 21, 2017
The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in diseaseDanielle Y F Twum, Lauren Burkard-Mandel, Scott I Abrams
Prehospital and Disaster Medicine|March 9, 1993
Guidelines for rescue training of the lay publicJ I Abrams, E A Pretto, D Angus, et al.
Current Infectious Disease Reports|May 22, 2014
Non-AIDS-Defining Malignancies in the HIV-Infected PopulationChia-Ching J Wang, Michael J Silverberg, Donald I Abrams
Cellular Immunology|March 1, 1993
Detachment and lysis of adherent target cells by CD4+ T cell clones involve multiple effector mechanismsS I Abrams, R Wang, W E Munger, et al.
MEDICC Review|May 19, 2018
Case Study in International Cooperation: Cuba's Molecular Immunology Center and Roswell Park Cancer InstituteRachel Evans, Mary Reid, Brahm Segal, et al.
Pageof 38